Our website is made possible by displaying online advertisements to our visitors.
Please consider supporting us by disabling your ad blocker.

PHARMA

Quarterly rpt on consolidated results for the financial period ended 30 Jun 2018

PHARMANIAGA BERHAD

Financial Year End 31 Dec 2018
Quarter 2 Qtr
Quarterly report for the financial period ended 30 Jun 2018
The figures have not been audited

Attachments

Pharma Q2 2018.pdf
386.8 kB

  • Default Currency
  • Other Currency

Currency: Malaysian Ringgit (MYR)

SUMMARY OF KEY FINANCIAL INFORMATION
30 Jun 2018

 
INDIVIDUAL PERIOD
CUMULATIVE PERIOD
CURRENT YEAR QUARTER
PRECEDING YEAR
CORRESPONDING
QUARTER
CURRENT YEAR TO DATE
PRECEDING YEAR
CORRESPONDING
PERIOD
30 Jun 2018
30 Jun 2017
30 Jun 2018
30 Jun 2017
$$'000
$$'000
$$'000
$$'000
1 Revenue
582,729
517,967
1,200,652
1,136,261
2 Profit/(loss) before tax
11,970
10,150
40,677
37,927
3 Profit/(loss) for the period
5,766
9,751
23,355
29,009
4 Profit/(loss) attributable to ordinary equity holders of the parent
5,394
9,520
22,980
28,443
5 Basic earnings/(loss) per share (Subunit)
2.08
3.67
8.84
10.97
6 Proposed/Declared dividend per share (Subunit)
4.00
4.00
9.00
8.00


AS AT END OF CURRENT QUARTER
AS AT PRECEDING FINANCIAL YEAR END
7
Net assets per share attributable to ordinary equity holders of the parent ($$)
2.0000
2.0300

Definition of Subunit:

In a currency system, there is usually a main unit (base) and subunit that is a fraction amount of the main unit.
Example for the subunit as follows:

Country Base Unit Subunit
Malaysia Ringgit Sen
United States Dollar Cent
United Kingdom Pound Pence




Announcement Info

Company Name PHARMANIAGA BERHAD
Stock Name PHARMA
Date Announced 17 Aug 2018
Category Financial Results
Reference Number FRA-13082018-00001